Skip to contentScholarGate
LibraryBookshelfDeskReview StudioAssistant
Sign in
On this page
IntuitionHow it worksWhen to use itStrengths & limitationsCommon pitfallsApplicationsFrequently asked🔒 Read the full methodSourcesRelated methods
Cite this pageSpotted an issue on this page? Report or suggest a fix →
Home›Epidemiology›Bayesian Case Series — Bayesian Case Series Analysis
Process / pipelineClinical / epidemiology

Bayesian Case Series — Bayesian Case Series Analysis

Bayesian Case Series Analysis · Also known as: Bayesian case-series, BCS analysis, Bayesian self-controlled case series, Bayesian SCCS

Bayesian case series is an observational epidemiological method that applies Bayesian inference to case series data — typically records of patients who experienced both a drug or vaccine exposure and an adverse health event. By incorporating prior evidence and computing posterior estimates of the incidence rate ratio within pre-specified risk windows, the method quantifies the strength of a temporal association between an exposure and an outcome while controlling for fixed individual-level confounding.

ScholarGate
  1. Process / pipeline
  2. v1
  3. 2 Sources
  4. PUBLISHED
Cite this page →
Tools & resources
Download slides
Learn & explore

Read the full method

Members only

Sign in with a free account to read this section.

Sign in

Method map

The neighbourhood of related methods — select a node to explore.

Bayesian Case Series
Cohort StudySelf-Controlled Case Ser…

When to use it

Use Bayesian case series when you have longitudinal individual-level records of adverse events following a drug or vaccine exposure, and your goal is to estimate the incidence rate ratio while controlling for fixed individual confounding. It is especially valuable in pharmacovigilance and vaccine safety surveillance where prior information from pre-clinical studies or analogous products is available and should be incorporated formally. Do not use it when time-varying confounders are likely (e.g., confounding by indication that changes over time), when events are recurrent and dependent, when the exposure period and event risk window overlap in complex ways across individuals, or when the dataset contains very few cases — Bayesian updating improves estimates but does not rescue severely underpowered studies.

Strengths & limitations

Strengths
  • Controls for all fixed individual-level confounders by design, eliminating the need to measure or adjust for time-invariant variables.
  • Formally incorporates prior evidence from pre-clinical studies, mechanistic knowledge, or historical surveillance data through the prior distribution.
  • Produces a full posterior distribution over the incidence rate ratio, yielding calibrated uncertainty quantification beyond a simple p-value.
  • Supports sequential updating: the posterior from one batch of data becomes the prior for the next, enabling real-time safety surveillance.
  • Well-suited to sparse data settings where classical frequentist methods produce unstable estimates.
Limitations
  • Assumes events are independent given the exposure; violates in the presence of recurrent, dependent events or when an event alters the probability of further exposure.
  • Does not control for time-varying confounders such as seasonal illness or concurrent medications that vary within individuals.
  • The choice of prior can materially influence results in small samples; weak or mis-specified priors may understate or inflate the signal.
  • Requires complete and unbiased case ascertainment; outcome misclassification or selective reporting of adverse events undermines validity.

Frequently asked

How is a Bayesian case series different from a standard self-controlled case series?

The standard SCCS uses classical (frequentist) conditional Poisson regression and produces a maximum-likelihood estimate and confidence interval. A Bayesian case series places a prior distribution on the incidence rate ratio and produces a full posterior distribution. The Bayesian version formally incorporates prior evidence, supports sequential updating as new data arrive, and yields a credible interval that can be directly interpreted as a probability statement about the parameter.

What prior distribution should I use?

A weakly informative log-normal prior on the log incidence rate ratio — centred at 0 (corresponding to IRR = 1) with moderate variance — is a common default that allows the data to dominate unless they are very sparse. If historical data from similar compounds or pre-clinical studies exist, a more informative prior can be justified, but sensitivity analyses under alternative priors should always be reported so readers can assess how much the conclusions depend on prior assumptions.

Can I use this method with spontaneous adverse event reports rather than electronic health records?

Yes, but with important caveats. Spontaneous reporting systems suffer from under-reporting, reporting biases (notoriety bias, Weber effect), and absence of denominator data. Bayesian case series applied to spontaneous reports can estimate disproportionality but not true incidence rate ratios. Methods like Bayesian Information Component (BIC) or the Gamma Poisson Shrinker were specifically developed for spontaneous reporting databases and are more appropriate for that data source.

What sample size is needed?

There is no universal minimum, but extremely sparse data — fewer than five events in total across all cases — will yield highly uncertain posteriors regardless of the prior. In practice, Bayesian case series is most useful when at least 10–30 events are available. The Bayesian framework handles small samples better than frequentist SCCS because the prior stabilises estimates, but a genuinely underpowered study cannot be rescued by the statistical framework alone.

What if the outcome can recur within the same individual?

Standard case series methods assume either a single non-recurrent event or independent recurrent events. If events are recurrent and the occurrence of one event affects the probability of a subsequent event (e.g., seizures), the independence assumption is violated. Extended SCCS models for recurrent dependent events have been developed by Farrington and colleagues and should be used instead of the standard formulation.

Sources

  1. Strom, B. L. (Ed.). (2001). Pharmacoepidemiology (3rd ed.). Wiley. [Chapter on case series and signal detection] link ↗
  2. Whitaker, H. J., Farrington, C. P., Spiessens, B., & Musonda, P. (2006). Tutorial in biostatistics: The self-controlled case series method. Statistics in Medicine, 25(10), 1768–1797. DOI: 10.1002/sim.2302 ↗

How to cite this page

ScholarGate. (2026, June 3). Bayesian Case Series Analysis. ScholarGate. https://scholargate.app/en/epidemiology/bayesian-case-series

Related methods

Cohort StudySelf-Controlled Case Series

Which method?

Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.

  • Cohort StudyEpidemiology↔ compare
  • Self-Controlled Case SeriesSocial Epidemiology↔ compare
Compare side by side →

Similar methods

Self-Controlled Case SeriesBayesian Phase IV studyBayesian Cohort StudyBayesian Cohort ResearchBayesian Case-Control StudyBayesian Case-Crossover DesignBayesian nested case-controlBayesian Randomized Clinical Trial

Related reference concepts

Signal Detection and Statistical AssessmentRisk Identification and CharacterizationAdverse Event Reporting and PharmacovigilanceBayesian Forecasting in Personalized DosingPharmacovigilance, Adverse Event Reporting, and Post-Market SurveillancePharmacovigilance Systems and Reporting

Spotted an issue on this page? Report or suggest a fix →

ScholarGate — Bayesian Case Series (Bayesian Case Series Analysis). Retrieved 2026-07-20 from https://scholargate.app/en/epidemiology/bayesian-case-series · Dataset: https://doi.org/10.5281/zenodo.20539026
Quick facts
Originator
Farrington, Whitaker, and colleagues (self-controlled case series); Bayesian extension by multiple authors in pharmacovigilance
Year
1995–2006 (core SCCS method 1995; Bayesian extensions throughout 2000s)
Type
Observational analytical study design with Bayesian inference
DataType
Individual-level longitudinal event data (hospitalisation records, adverse event reports, electronic health records)
Subfamily
Clinical / epidemiology
Related methods
Cohort StudySelf-Controlled Case Series
ScholarGate

A content-first reference library for research methods — what each one is, how it works, and where it comes from.

Open data (CC-BY)

Explore

  • Library
  • Search the library…
  • Browse by field
  • Fields
  • Journey
  • Compare
  • Which method?

Reference

  • Subjects
  • Atlas
  • Glossary
  • Methodology
  • Philosophy

Your tools

  • Bookshelf
  • Desk
  • Chat

Company

  • About
  • Pricing
  • Contact
  • Suggest a method

Entries are compiled from published sources for reference. Verifying the accuracy and suitability of any information for your own use remains your responsibility.

© 2026 ScholarGate · A research-method reference library
  • Privacy
  • Cookies
  • Terms
  • Delete account